search
Back to results

Splenic Injury Embolization - the Question About NOM (SInE Qua NOM)

Primary Purpose

Wounds and Injuries

Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Embolization
Sponsored by
Oslo University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wounds and Injuries focused on measuring Non-operative management, Splenic Injury, Blunt, Splenic artery embolization, Trauma

Eligibility Criteria

16 Years - 80 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • blunt splenic injury OIS grade 4 or 5
  • Adult trauma patients (according to local definitions)
  • Present hemodynamically normal as judged by the responsible trauma consultant surgeon and eligible for NOM
  • Randomised within 48 hours of injury
  • Written informed consent is obtained

Exclusion Criteria:

  • Hemodynamically compromised (not suitable for NOM)
  • Needing transfusions
  • CT shows evidence of significant contrast extravasation
  • Other indications for laparotomy
  • Prisoners
  • Pregnant
  • >80 years old
  • Penetrating injury
  • Contraindication to iv contrast

Sites / Locations

  • Denver Health Medical Center
  • University of Pittsburgh School of Medicine
  • Harborview Medical Center
  • Liverpool Hospital
  • McGill University Health Centre
  • Rigshospitalet
  • Kliniken der Stadt Köln
  • University Medical Center
  • Oslo Universtity HospitalRecruiting
  • Karolinska Institute
  • Royal London Hospital
  • Nottingham University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Embolization

Observation

Arm Description

The intervention arm will perform SAE as a central embolization of the splenic artery. Additional peripheral embolization is left to the discretion of the interventional radiologist. The study does not interfere with local diagnostic work-up and treatment protocols.

The control arm in this randomized controlled trial will include only NOM patients diagnosed with splenic injuries OIS grade 4 or 5 and suitable for observation alone, and will comprise clinical observation according to local routines and protocols.

Outcomes

Primary Outcome Measures

Failure of NOM
The primary objective is to compare the failure rate due to splenic bleeding between the patients undergoing pre-emptive SAE as part of NOM and the patients not undergoing SAE. The primary endpoint is the proportion of subjects failing NOM due to spleen related bleeding within 7 days of injury. All analyses will be based on an intention to treat analysis.

Secondary Outcome Measures

Delayed bleeding episode
Incidence. Delayed bleeding episode is defined as hemodynamically unstable patient, CT verified contrast blush or drop in hemoglobin/hematocrit.
All cause and spleen related mortality
Incidence
All cause and spleen related failure of NOM
Incidence
Pseudoaneurysms (PSA)
Incidence
Symptomatic thromboembolic events
Incidence
Other spleen related complications
Incidence
Angiography related complications
Incidence

Full Information

First Posted
July 5, 2017
Last Updated
July 25, 2017
Sponsor
Oslo University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03231202
Brief Title
Splenic Injury Embolization - the Question About NOM (SInE Qua NOM)
Official Title
A Multi-centre, Prospective, Randomized Controlled Study to Compare Outcomes of Non-operative Management (NOM) With and Without Splenic Arterial Embolization (SAE) in Hemodynamically Stable OIS Grade 4 and 5 Splenic Injuries.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2017
Overall Recruitment Status
Unknown status
Study Start Date
July 1, 2017 (Actual)
Primary Completion Date
August 1, 2019 (Anticipated)
Study Completion Date
August 1, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary objective is to compare the failure rate due to splenic bleeding between the patients undergoing pre-emptive splenic arterial embolization (SAE) as part of non-operative management (NOM) and the patients not undergoing SAE. We hypothesize that the use of pre-emptive SAE will decrease the delayed bleeding rate and increase the success rate of NOM.
Detailed Description
This randomised controlled study will follow the clinical course of hemodynamically normal trauma patients with Organ Injury Scale (OIS) grade 4 or 5 blunt splenic injuries, undergoing SAE or observation only until day 7 post injury. Only hemodynamically normal patients will be considered for enrolment into the study, and written informed consent from the patient is required. CONTROL The control arm in this randomized controlled trial will include only NOM patients diagnosed with splenic injuries OIS grade 4 or 5 and suitable for observation alone, and will comprise clinical observation according to local routines and protocols. The patients will be observed with special focus on delayed bleeding and failure of NOM. A contrast enhanced US or CT scan with arterial phase will be performed on day 3-5 to exclude PSA. On day 7, the decision to perform SAE, splenectomy or continue NOM is left to the discretion of each participating institution, and registered in the case report form (CRF). INTERVENTION The intervention arm will perform SAE as a central embolization of the splenic artery. Additional peripheral embolization is left to the discretion of the interventional radiologist. Each institution decides whether patients in the SAE group are to undergo immunization or not. The study does not interfere with local diagnostic work-up and treatment protocols. We hypothesize that the use of pre-emptive SAE will decrease the delayed bleeding rate and increase the success rate of NOM leading to fewer splenectomies in this group of patients without concomitant increased complication rates. Additionally, we want to explore the effects of pre-emptive SAE vs observation alone on all cause failure rate, operative procedures, repeat angiography rate, complications, critical care stay, and mortality.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wounds and Injuries
Keywords
Non-operative management, Splenic Injury, Blunt, Splenic artery embolization, Trauma

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
224 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Embolization
Arm Type
Experimental
Arm Description
The intervention arm will perform SAE as a central embolization of the splenic artery. Additional peripheral embolization is left to the discretion of the interventional radiologist. The study does not interfere with local diagnostic work-up and treatment protocols.
Arm Title
Observation
Arm Type
No Intervention
Arm Description
The control arm in this randomized controlled trial will include only NOM patients diagnosed with splenic injuries OIS grade 4 or 5 and suitable for observation alone, and will comprise clinical observation according to local routines and protocols.
Intervention Type
Procedure
Intervention Name(s)
Embolization
Other Intervention Name(s)
Splenic artery embolization (SAE)
Intervention Description
The intervention arm will perform SAE as a central embolization of the splenic artery. Additional peripheral embolization is left to the discretion of the interventional radiologist.
Primary Outcome Measure Information:
Title
Failure of NOM
Description
The primary objective is to compare the failure rate due to splenic bleeding between the patients undergoing pre-emptive SAE as part of NOM and the patients not undergoing SAE. The primary endpoint is the proportion of subjects failing NOM due to spleen related bleeding within 7 days of injury. All analyses will be based on an intention to treat analysis.
Time Frame
7 days
Secondary Outcome Measure Information:
Title
Delayed bleeding episode
Description
Incidence. Delayed bleeding episode is defined as hemodynamically unstable patient, CT verified contrast blush or drop in hemoglobin/hematocrit.
Time Frame
6-12 weeks
Title
All cause and spleen related mortality
Description
Incidence
Time Frame
6-12 weeks
Title
All cause and spleen related failure of NOM
Description
Incidence
Time Frame
6-12 weeks
Title
Pseudoaneurysms (PSA)
Description
Incidence
Time Frame
6-12 weeks
Title
Symptomatic thromboembolic events
Description
Incidence
Time Frame
6-12 weeks
Title
Other spleen related complications
Description
Incidence
Time Frame
6-12 weeks
Title
Angiography related complications
Description
Incidence
Time Frame
6-12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: blunt splenic injury OIS grade 4 or 5 Adult trauma patients (according to local definitions) Present hemodynamically normal as judged by the responsible trauma consultant surgeon and eligible for NOM Randomised within 48 hours of injury Written informed consent is obtained Exclusion Criteria: Hemodynamically compromised (not suitable for NOM) Needing transfusions CT shows evidence of significant contrast extravasation Other indications for laparotomy Prisoners Pregnant >80 years old Penetrating injury Contraindication to iv contrast
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
iver Anders Gaski, MD
Phone
90063971
Ext
0047
Email
iagaski@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Christine Gaarder, MD, PhD
Phone
41318992
Ext
0047
Email
tinagaar@onliine.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christine Gaarder, MD, PhD
Organizational Affiliation
Head, Department of Traumatology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Denver Health Medical Center
City
Denver
State/Province
Colorado
ZIP/Postal Code
80204
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eric Campion
Facility Name
University of Pittsburgh School of Medicine
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Louis Alarcon
Facility Name
Harborview Medical Center
City
Seattle
State/Province
Washington
ZIP/Postal Code
98104
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ron Maier
First Name & Middle Initial & Last Name & Degree
Josph Cushieri
Facility Name
Liverpool Hospital
City
Sydney
Country
Australia
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Scott D'Amours
Facility Name
McGill University Health Centre
City
Montreal
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tarek Razek
Facility Name
Rigshospitalet
City
Copenhagen
Country
Denmark
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Poul Svenningsen
Facility Name
Kliniken der Stadt Köln
City
Cologne
Country
Germany
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marc Maegele
Facility Name
University Medical Center
City
Utrecht
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luke Leenen
Facility Name
Oslo Universtity Hospital
City
Oslo
ZIP/Postal Code
0450
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
iver Anders Gaski, MD
Phone
90063971
Email
iagaski@gmail.com
First Name & Middle Initial & Last Name & Degree
Knut Magne Kolstadbraten
Phone
92212577
Ext
0047
Email
KKOLSTAD@ous-hf.no
Facility Name
Karolinska Institute
City
Stockholm
Country
Sweden
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lovisa Strømmer
First Name & Middle Initial & Last Name & Degree
Susanna Eriksson
Facility Name
Royal London Hospital
City
London
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karim Brohi
Facility Name
Nottingham University Hospital
City
Nottingham
Country
United Kingdom
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adam Brooks

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23114484
Citation
Stassen NA, Bhullar I, Cheng JD, Crandall ML, Friese RS, Guillamondegui OD, Jawa RS, Maung AA, Rohs TJ Jr, Sangosanya A, Schuster KM, Seamon MJ, Tchorz KM, Zarzuar BL, Kerwin AJ; Eastern Association for the Surgery of Trauma. Selective nonoperative management of blunt splenic injury: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg. 2012 Nov;73(5 Suppl 4):S294-300. doi: 10.1097/TA.0b013e3182702afc.
Results Reference
result
PubMed Identifier
20479344
Citation
Velmahos GC, Zacharias N, Emhoff TA, Feeney JM, Hurst JM, Crookes BA, Harrington DT, Gregg SC, Brotman S, Burke PA, Davis KA, Gupta R, Winchell RJ, Desjardins S, Alouidor R, Gross RI, Rosenblatt MS, Schulz JT, Chang Y. Management of the most severely injured spleen: a multicenter study of the Research Consortium of New England Centers for Trauma (ReCONECT). Arch Surg. 2010 May;145(5):456-60. doi: 10.1001/archsurg.2010.58.
Results Reference
result
PubMed Identifier
9637156
Citation
Davis KA, Fabian TC, Croce MA, Gavant ML, Flick PA, Minard G, Kudsk KA, Pritchard FE. Improved success in nonoperative management of blunt splenic injuries: embolization of splenic artery pseudoaneurysms. J Trauma. 1998 Jun;44(6):1008-13; discussion 1013-5. doi: 10.1097/00005373-199806000-00013.
Results Reference
result
PubMed Identifier
7473916
Citation
Schurr MJ, Fabian TC, Gavant M, Croce MA, Kudsk KA, Minard G, Woodman G, Pritchard FE. Management of blunt splenic trauma: computed tomographic contrast blush predicts failure of nonoperative management. J Trauma. 1995 Sep;39(3):507-12; discussion 512-3. doi: 10.1097/00005373-199509000-00018.
Results Reference
result
PubMed Identifier
15967903
Citation
McIntyre LK, Schiff M, Jurkovich GJ. Failure of nonoperative management of splenic injuries: causes and consequences. Arch Surg. 2005 Jun;140(6):563-8; discussion 568-9. doi: 10.1001/archsurg.140.6.563.
Results Reference
result
PubMed Identifier
1887032
Citation
Sclafani SJ, Weisberg A, Scalea TM, Phillips TF, Duncan AO. Blunt splenic injuries: nonsurgical treatment with CT, arteriography, and transcatheter arterial embolization of the splenic artery. Radiology. 1991 Oct;181(1):189-96. doi: 10.1148/radiology.181.1.1887032.
Results Reference
result
PubMed Identifier
24655852
Citation
Miller PR, Chang MC, Hoth JJ, Mowery NT, Hildreth AN, Martin RS, Holmes JH, Meredith JW, Requarth JA. Prospective trial of angiography and embolization for all grade III to V blunt splenic injuries: nonoperative management success rate is significantly improved. J Am Coll Surg. 2014 Apr;218(4):644-8. doi: 10.1016/j.jamcollsurg.2014.01.040. Epub 2014 Jan 28.
Results Reference
result
PubMed Identifier
22673236
Citation
Bhullar IS, Frykberg ER, Siragusa D, Chesire D, Paul J, Tepas JJ 3rd, Kerwin AJ. Selective angiographic embolization of blunt splenic traumatic injuries in adults decreases failure rate of nonoperative management. J Trauma Acute Care Surg. 2012 May;72(5):1127-34. doi: 10.1097/TA.0b013e3182569849.
Results Reference
result
PubMed Identifier
26772452
Citation
Schimmer JA, van der Steeg AF, Zuidema WP. Splenic function after angioembolization for splenic trauma in children and adults: A systematic review. Injury. 2016 Mar;47(3):525-30. doi: 10.1016/j.injury.2015.10.047. Epub 2015 Nov 19.
Results Reference
result
PubMed Identifier
15761342
Citation
Haan JM, Bochicchio GV, Kramer N, Scalea TM. Nonoperative management of blunt splenic injury: a 5-year experience. J Trauma. 2005 Mar;58(3):492-8. doi: 10.1097/01.ta.0000154575.49388.74.
Results Reference
result
PubMed Identifier
20673894
Citation
Skattum J, Titze TL, Dormagen JB, Aaberge IS, Bechensteen AG, Gaarder PI, Gaarder C, Heier HE, Naess PA. Preserved splenic function after angioembolisation of high grade injury. Injury. 2012 Jan;43(1):62-6. doi: 10.1016/j.injury.2010.06.028. Epub 2010 Jul 31.
Results Reference
result
PubMed Identifier
16038813
Citation
Peitzman AB, Harbrecht BG, Rivera L, Heil B; Eastern Association for the Surgery of Trauma Multiinstitutional Trials Workgroup. Failure of observation of blunt splenic injury in adults: variability in practice and adverse consequences. J Am Coll Surg. 2005 Aug;201(2):179-87. doi: 10.1016/j.jamcollsurg.2005.03.037.
Results Reference
result
PubMed Identifier
24004931
Citation
Cirocchi R, Boselli C, Corsi A, Farinella E, Listorti C, Trastulli S, Renzi C, Desiderio J, Santoro A, Cagini L, Parisi A, Redler A, Noya G, Fingerhut A. Is non-operative management safe and effective for all splenic blunt trauma? A systematic review. Crit Care. 2013 Sep 3;17(5):R185. doi: 10.1186/cc12868.
Results Reference
result
PubMed Identifier
19509611
Citation
Zarzaur BL, Vashi S, Magnotti LJ, Croce MA, Fabian TC. The real risk of splenectomy after discharge home following nonoperative management of blunt splenic injury. J Trauma. 2009 Jun;66(6):1531-6; discussion 1536-8. doi: 10.1097/TA.0b013e3181a4ed11.
Results Reference
result
PubMed Identifier
22410104
Citation
Clancy AA, Tiruta C, Ashman D, Ball CG, Kirkpatrick AW. The song remains the same although the instruments are changing: complications following selective non-operative management of blunt spleen trauma: a retrospective review of patients at a level I trauma centre from 1996 to 2007. J Trauma Manag Outcomes. 2012 Mar 13;6(1):4. doi: 10.1186/1752-2897-6-4.
Results Reference
result

Learn more about this trial

Splenic Injury Embolization - the Question About NOM (SInE Qua NOM)

We'll reach out to this number within 24 hrs